| INTRODUC TI ON
The monitoring of substitution therapy in patients with haemophilia A is dependent on the accurate measurement of factor VIII (FVIII) activity over a large concentration range. The evaluation of FVIII levels in the normal range is critical during surgical intervention, whereas the evaluation of FVIII levels in the low range is mainly important during prophylaxis.
The availability of extended half-life recombinant FVIII (EHL- 
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Therefore, assays and their reagents must be carefully selected in relation to the EHL-rFVIII being measured. For this reason, many studies were carried out with spiked samples with known FVIII levels.
Despite the selection of suitable assays for the reliable measurement of EHL-rFVIII, international studies have reported an overestimation of the concentration of these molecules when the FVIII-level was lower than 5 IU/dL. 1, 4 In spite of using the recommended coagulation assays and correction factor for the measurement of Afstyla 
. In a sample spiked with 3 IU/dL, however, the recovery of the same product reached a mean of 213.5%. 4 Interestingly, during this study calibration of the assay with a product-specific standard improved the recovery in the normal range, but not in the low range. 4 A similar overestimation of low FVIII activity was observed in another multicentre study.
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It is unlikely that this overestimation of low FVIII levels is solely caused by the poor reproducibility of the assays, because in this case a clear trend towards overestimation would not have been observed.
Previous studies have indicated the use of diluent buffer instead of FVIII deficient plasma for the dilution of the reference material as a potential cause of overestimation in the low FVIII concentration range. 6, 7 However, despite these publications, the preparation of calibration curves by diluting the reference material in FVIII-deficient plasma is not always the standard in local laboratories.
Moreover, this procedure is not systematically recommended by the companies that provide the automated coagulation instruments and coagulation reagents. We therefore studied the impact of the use of different reagents in the preparation of calibration curves on the measurement of different types of FVIII.
| MATERIAL S AND ME THODS

| One-stage clotting assay and reagents
The one-stage FVIII clotting assay was performed on an ACL-TOP500 
| Calibration curves
The assay was calibrated with an in-house pooled normal plasma- 
| Parallelism testing
To reduce the risk of reporting falsely low FVIII levels due to the presence of lupus anticoagulant, the measurement of multiple dilutions of each plasma sample is recommended. 9 The result is only valid if the sample dilution curves are parallel to the calibration curve. Parallelism was assessed by calculating the intra-assay coefficients of variation (CVs) obtained with different dilutions of the samples. The samples and the calibration curves were considered parallel over the range of the assay when the intra-assay CV was <20%.
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Three automated dilution methods were compared. In the first method, the samples were prediluted two-and fourfold with FVIIIdeficient plasma (Siemens) as recommended by Cinotti et al. 6 In the second method, the samples were prediluted with diluent buffer.
These additional sample dilutions were already programmed by the manufacturer in the ACL-TOP500. The samples were diluted two- 
| Measurement of FVIII levels in commercial FVIII-deficient plasma
The FVIII levels in the different commercial FVIII-deficient plasmas were verified with a FVIII one-stage assay using plasma from a patient with severe haemophilia A (inversion of intron 22) as substrate and calibrated with the reference standard.
| RE SULTS
| Generation of calibration curves with diluent buffer or FVIII-deficient plasma
Calibration curves were generated by diluting a pool of plasma standard with either diluent buffer or the FVIII-deficient plasma used as substrate plasma for the coagulation assay. Coagulation times recorded after dilution of the reference standard with diluent buffer were significantly longer than those recorded after dilution with FVIII-deficient plasma for calibrator mixtures containing <25 IU/dL FVIII (paired t test, P ≤ 0.05; Figure 1) . Importantly, the F I G U R E 1 Generation of FVIII calibration curves with diluent buffer or FVIII-deficient plasma. Eight-point calibration curves were generated by diluting an in-house pooled normal plasma standard with either diluent buffer or FVIII-deficient plasma. A, Siemens; B, Werfen; C, Grifols FVIII-deficient plasma. Data are shown as the mean of triplicates. The mean CV of the triplicates was ≤2%
coagulation time recorded with diluent buffer was 12-15 seconds longer than that measured with FVIII-deficient plasmas (Figure 1 
| Overestimation of low FVIII levels with calibration curve generated in diluent buffer
The differences between the calibration curves generated with diluent buffer and with FVIII-deficient plasma suggested that the measurement of low FVIII concentrations could be significantly biased depending on the matrix of the calibration curves. We therefore measured FVIII levels in FVIII-deficient plasma (Grifols) spiked with an FVIII plasma pool, an FL-rFVIII (Advate ® ) and an EHL-rFVIII (Elocta ® ), using calibration curves generated with either diluent buffer or FVIII-deficient plasma. In these experiments, the samples were analysed after a 10-fold dilution rather than after multiple dilutions (the parallelism method) to avoid differences in the matrix of the assay.
Factor VIII levels of between 70%-130% of the expected values were obtained with the calibration curve generated with FVIII-deficient plasmas for all samples spiked with at least 0.8 IU/dL of any of the three types of FVIII (Tables 1-3) . By contrast, the FVIII levels analysed with the calibration curve generated in diluent buffer were overestimated by 132%-600% in the samples containing <25 IU/dL FVIII. In addition, FVIII activity of about 1 IU/dL was measured in the control FVIII-deficient plasma that had not been spiked with any FVIII when the calibration curve generated in diluent buffer was employed (Tables 1-3 Factor VIII levels were also measured in FVIII-deficient plasma spiked with Afstyla ® . When using the calibration curve generated with FVIII-deficient plasma and when applying the correction factor of 2 that is recommended by the manufacturer, the recovery of FVIII in samples spiked with 0.6-80 IU/dL Afstyla ® ranged from 70% to 88%. By contrast, when using the calibration curve generated with diluent buffer, the recovery ranged from 105% with the sample spiked with 80 IU/dL to 353% with the sample spiked with 0.6 IU/dL Afstyla ® (Figure 2 ).
| Parallelism
Factor VIII-deficient plasma samples, spiked with 100, 30, 10 and 3 IU/dL plasma FVIII, respectively, were analysed using three dilutions. FVIII levels lower than 0.5 IU/dL in the diluted samples were not taken into account for the analysis. As shown in Figure 3 , a lack of parallelism (intra-assay CVs ≥20%) was observed for samples containing ≤30 IU/dL FVIII when the dilution was carried out with diluent buffer. By contrast, by diluting the sample in FVIII-deficient plasma or by using the method with diluent supplemented with 10%
FVIII-deficient plasma, the intra-assay CVs of the spiked samples Calibration curves were generated by diluting a pool of plasma standard with FVIII-deficient plasma (Grifols), which was also used as substrate plasma for the coagulation assays, or with diluent buffer. Samples were prepared by diluting a plasma pool with FVIII-deficient plasma. Results are expressed as the mean ± SD of FVIII:C in triplicates and as a % of the expected recovery. FVIII levels higher than 130% or lower than 70% of the expected recoveries are highlighted in bold. NC, not calculated. >>, the recovery is higher than expected but cannot be calculated because the divisor is 0.
TA B L E 1 Measurement of FVIII levels in FVIII-deficient plasma spiked with plasma FVIII
Expected recovery (IU/dL)
Calibrator in FVIII-deficient plasma Calibrator in diluent buffer
FVIII:C (IU/dL)
were ≤11.1%. Accordingly, both methods provided an acceptable parallelism between the samples and the calibrator dilution curves.
| D ISCUSS I ON
An important overestimation of low plasma FVIII, rFVIII and EHLrFVIII levels has been reported in several studies. Calibration curves were generated by diluting a pool of plasma standard with FVIII-deficient plasma (Grifols), which was also used as substrate plasma for the coagulation assays, or with diluent buffer. Samples were prepared by spiking FVIII-deficient plasma with Advate
Results are expressed as the mean ± SD of FVIII:C of three experiments carried out with triplicates and as a % of the expected recovery. FVIII levels higher than 130% or lower than 70% of the expected recoveries are highlighted in bold. NC, not calculated. >>, the recovery is higher than expected but cannot be calculated because the divisor is 0. Calibration curves were generated by diluting a pool of plasma standard with FVIII-deficient plasma (Grifols), which was used as substrate plasma for the coagulation assays, or with diluent buffer. Samples were prepared by spiking FVIII-deficient plasma with Elocta ® . Results are expressed as the mean ± SD of FVIII:C in triplicates and as a % of the expected recovery. FVIII levels higher than 130% or lower than 70% of the expected recoveries are highlighted in bold. NC, not calculated. >>, the recovery is higher than expected but cannot be calculated because the divisor is 0.
TA B L E 3 Measurement of FVIII levels in FVIII-deficient plasma spiked with Elocta
Accordingly, this problem is likely relevant both for the monitoring of trough levels in patients treated with FVIII concentrates and for the diagnosis of moderate or severe haemophilia A.
The cause of overestimation of low FVIII levels with calibration curves generated with diluent buffer instead of FVIII deficient plasma is that the coagulation time of diluent buffer used as a zero point of the calibration curve is longer than that of FVIII-deficient plasma, as previously reported when measuring FVIII in plasma FVIII and plasma-derived concentrates. 6, 7 The reasons for coagulation times recorded with diluent buffer being longer than with FVIII-deficient plasma have been explored by Frandsen et al. 7 These observations suggested that vitamin-K dependent factors, FV and fibrinogen brought by the sample (aside from FVIII) contributed to accelerating the coagulation reaction. Interestingly, the difference between the two types of calibration was not due to the amount of VWF brought by the sample. Indeed, a similar difference was observed between calibration curves generated with diluent buffer and with FVIII-deficient plasma without VWF or with FVIII-deficient plasma containing normal levels of VWF. . Calibration curves were generated by diluting a pool of plasma standard with FVIII-deficient plasma (Siemens), which was also used as substrate plasma for the coagulation assays, or with diluent buffer. Samples were prepared by spiking FVIIIdeficient plasma with Afstyla ® . The FVIII levels were multiplied by a correction factor of 2 as recommended by the company.
1 Results are expressed as the mean ± SD of triplicates of the expected FVIII recovery F I G U R E 3 Influence of sample dilution method on parallelism. The experiments were carried out with four samples prepared by supplementing FVIII-deficient plasma with different concentrations (100, 30, 10 and 3 U/dL) of a normal pool plasma. Three sample dilution methods were tested: A, Samples were undiluted or diluted two-or fourfold in diluent buffer and then further diluted 10-fold in diluent buffer; B, Samples were undiluted or diluted two-or fourfold in FVIII-deficient plasma and then further diluted 10-fold in diluent buffer; C, Samples were diluted 10-fold in diluent buffer and then analysed without further dilution or with two-or fourfold dilution in diluent buffer supplemented with 10% FVIII deficient plasma. All dilutions were carried out by the automated coagulometer. The mixtures generated by each dilution procedure were then added to the other reagents of the FVIII assay. The concentrations of FVIII in the diluted mixture were determined with a calibration curve generated with FVIII-deficient plasma. Results were calculated by multiplying the FVIII levels determined in the sample, undiluted or diluted two-or fourfold, by the dilution factor and were expressed as mean ± SD of triplicates. FVIII levels ≤0.5 IU/dL before mathematical correction by the dilution factor were not taken into account for the analysis of the data. The CV of the FVIII levels determined with the three dilutions of each spiked sample is indicated above the corresponding data. CV >20% identifies methods that do not correspond to the parallelism criteria One potential limitation of our study is that it was carried out with spiked samples rather than with patient plasma. Further study is needed to determine the differences between calibration curves generated in FVIII-deficient plasma and in diluent buffer when other reagents are used for the FVIII assay. We also Cinotti et al 6 also reported quantitative differences between FVIII assays carried out with calibration curves generated in different dilution buffers, although overestimations in the measurement of low FVIII levels were observed in all of them. We evaluated only the diluent buffer recommended by the manufacturer of the coagulation instrument. Accordingly, the range of differences between calibration curves generated with all commercially available FVIII-deficient plasmas and diluent buffers cannot be predicted.
Our study was carried out only with calibration curves generated with plasma as a calibrator rather than with product-specific standards. The rationale to calibrate only with plasma was that for the two rFVIIIs used in this study, the use of a product-specific standard was not recommended by the manufacturers. 3, 5 In addition, a recent study had shown that the error in the measurement of low FVIII levels was only marginally reduced by the use of a product-specific calibrator rather than plasma, indicating that other methodological aspects were responsible for the bias. 
| CON CLUS ION
Our data confirm that an important cause of overestimation of low FVIII levels is the generation of FVIII calibration curves in diluent buffer rather than in FVIII-deficient plasma. Such calibration curves do not compensate for the coagulation factors other than the FVIII brought by the sample in the FVIII coagulation assay. This overestimation of FVIII activity occurs with plasma-derived FVIII, rFVIII and modified EHL-rFVIII.
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